logo


MattsonJack Adds Indications to Epi Database
Wednesday, July 01, 2009 10:00 AM


(Source: MARKETWIRE)trackingThe Mattson Jack Group, Inc. (MattsonJack), the recognized thought leader in business analytics and strategic decision support for the pharmaceutical and healthcare industries, today announced the addition of five indications to Epi Database - BRIC, the premier Web-accessible database that provides researched, documented, and comprehensive epidemiology data in significant emerging markets. In addition, MattsonJack updated the epidemiological data for 15 indications in the G7 countries in Epi Database. Epi Database is the premier resource of thoroughly researched and documented epidemiology data for more than 190 indications and procedures.

Epi Database - BRIC includes epidemiological data for Brazil, Russia, India, and China. It covers 93 indications, expanding to more than 120 by year-end, with the following indications added in June 2009:

 --  Diabetic nephropathy --  Diabetic retinopathy --  Meningitis --  Rabies --  Congestive heart failure      

"Despite the recent economic downturn, pharmaceutical spending in BRIC countries is still expected to increase at a healthy rate," says Dr. Charles Dharmani, Director of Epidemiology at MattsonJack. "Pharmaceutical companies need an in-depth understanding of the unique issues that affect these countries in order to capitalize on this growth opportunity."

Besides adding new indications to Epi Database - BRIC, MattsonJack also has updated the epidemiology data in Epi Database in the following indications in G7 countries:

 --  Meniere's disease --  Autism spectrum disorders --  Alopecia --  Pain --  Asthma --  Pulmonary arterial hypertension --  Peripheral arterial disease --  Gastroesophageal reflux disease (GERD) --  Posttraumatic stress disorder (PTSD) -- Europe and Japan only --  Panic disorder -- Europe only --  Alzheimer's disease -- Japan only --  Epilepsy -- Japan only --  Major depressive disorder -- Japan only --  Ulcerative colitis -- Japan only --  Schizophrenia -- Japan only      

Pharmaceutical companies use Epi Database and Epi Database - BRIC to support major product decisions, including:

 --  Market definitions / potential / sizing --  Go / no-go decisions --  New revenue opportunities for in-line products --  Understanding previously untapped growth opportunities / markets      

For more information about Epi Database and Epi Database - BRIC, please visit http://www.mattsonjack.com/epidatabase.asp.

For more information on MattsonJack service offerings, products, or thought leadership, contact Paula Paradise, Director of Marketing, MattsonJack Public Relations, at paula.paradise@mattsonjack.com or by phone in the U.S. (484.442.1431).

ABOUT THE MATTSON JACK GROUP, INC.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia